A detailed history of Assenagon Asset Management S.A. transactions in Johnson & Johnson stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 87,476 shares of JNJ stock, worth $12.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
87,476
Previous 80,834 8.22%
Holding current value
$12.8 Million
Previous $11.8 Million 19.99%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$145.48 - $167.38 $966,278 - $1.11 Million
6,642 Added 8.22%
87,476 $14.2 Million
Q2 2024

Jul 18, 2024

SELL
$144.38 - $157.78 $201,121 - $219,787
-1,393 Reduced 1.69%
80,834 $11.8 Million
Q1 2024

Apr 24, 2024

BUY
$155.22 - $162.74 $165,464 - $173,480
1,066 Added 1.31%
82,227 $13 Million
Q4 2023

Jan 17, 2024

BUY
$145.6 - $158.88 $51,251 - $55,925
352 Added 0.44%
81,161 $12.7 Million
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $176 Million - $198 Million
-1,131,988 Reduced 93.34%
80,809 $12.6 Million
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $10.9 Million - $11.7 Million
-70,367 Reduced 5.48%
1,212,797 $201 Million
Q1 2023

Apr 18, 2023

BUY
$151.05 - $180.26 $6.34 Million - $7.56 Million
41,944 Added 3.38%
1,283,164 $199 Million
Q4 2022

Jan 12, 2023

BUY
$160.2 - $179.79 $82.4 Million - $92.5 Million
514,262 Added 70.74%
1,241,220 $219 Million
Q3 2022

Oct 27, 2022

BUY
$161.33 - $179.52 $41.1 Million - $45.7 Million
254,720 Added 53.94%
726,958 $119 Million
Q2 2022

Jul 27, 2022

SELL
$168.19 - $186.01 $70 Million - $77.5 Million
-416,455 Reduced 46.86%
472,238 $83.8 Million
Q1 2022

Apr 25, 2022

SELL
$158.14 - $179.59 $180 Million - $204 Million
-1,136,320 Reduced 56.11%
888,693 $158 Million
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $404,794 - $449,133
2,596 Added 0.13%
2,025,013 $346 Million
Q3 2021

Oct 19, 2021

BUY
$161.5 - $179.47 $268 Million - $298 Million
1,657,946 Added 454.89%
2,022,417 $327 Million
Q2 2021

Jul 15, 2021

BUY
$159.48 - $171.07 $22.3 Million - $23.9 Million
139,861 Added 62.27%
364,471 $60 Million
Q1 2021

Apr 26, 2021

SELL
$153.07 - $170.48 $105 Million - $117 Million
-686,441 Reduced 75.35%
224,610 $36.9 Million
Q4 2020

Feb 01, 2021

BUY
$137.11 - $157.38 $89.1 Million - $102 Million
649,649 Added 248.52%
911,051 $143 Million
Q3 2020

Oct 07, 2020

BUY
$140.38 - $153.83 $26 Million - $28.5 Million
184,993 Added 242.11%
261,402 $38.9 Million
Q2 2020

Jul 21, 2020

SELL
$128.81 - $155.51 $52.1 Million - $62.8 Million
-404,132 Reduced 84.1%
76,409 $10.7 Million
Q1 2020

Apr 17, 2020

BUY
$111.14 - $153.99 $29.7 Million - $41.1 Million
266,787 Added 124.81%
480,541 $63 Million
Q4 2019

Jan 17, 2020

SELL
$127.5 - $146.44 $185 Million - $212 Million
-1,447,750 Reduced 87.13%
213,754 $31.2 Million
Q3 2019

Oct 16, 2019

BUY
$126.95 - $142.14 $139 Million - $156 Million
1,094,696 Added 193.13%
1,661,504 $215 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $26.4 Million - $29 Million
201,355 Added 55.1%
566,808 $78.9 Million
Q1 2019

Apr 26, 2019

SELL
$125.72 - $139.79 $35.7 Million - $39.6 Million
-283,587 Reduced 43.69%
365,453 $51.1 Million
Q4 2018

Jan 23, 2019

BUY
$122.84 - $147.84 $76.2 Million - $91.7 Million
620,558 Added 2178.77%
649,040 $83.8 Million
Q3 2018

Oct 29, 2018

SELL
$121.58 - $142.88 $59.6 Million - $70.1 Million
-490,614 Reduced 94.51%
28,482 $3.94 Million
Q2 2018

Jul 17, 2018

BUY
$119.4 - $131.76 $61.2 Million - $67.5 Million
512,204 Added 7431.86%
519,096 $63 Million
Q1 2018

Apr 30, 2018

BUY
$125.1 - $148.14 $862,189 - $1.02 Million
6,892 New
6,892 $883,000
Q4 2017

Jan 25, 2018

SELL
$131.22 - $143.62 $205 Million - $224 Million
-1,561,922 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$129.47 - $135.38 $202 Million - $211 Million
1,561,922
1,561,922 $203 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.